What does “slowing down the progression” actually mean?

When we talk about the progression of Parkinson’s disease, we are not talking about stopping the disease itself, but rather about:

• maintaining mobility for as long as possible,
• delaying functional limitations,
• increasing safety and independence in everyday life.
  
  

The progression varies greatly from person to person. The decisive factor is how early and how specifically supportive measures are implemented.

What factors influence the progression of Parkinson’s disease?

The progression of Parkinson’s disease is influenced by, among other things:

• the onset and type of the disease,
• genetic and biological factors,
• drug therapy,
• activity level and movement behavior.
  
  

While biological factors cannot be influenced, targeted exercise therapy in particular can make an important contribution.

 
What role does exercise play?

Exercise is now considered a key component in managing Parkinson’s disease. Studies indicate that regular, structured exercise:

• can maintain mobility for longer,
• stabilizes everyday functions,
• can reduce the risk of falls.

However, not all exercise is equally effective. The decisive factor is whether exercise is targeted, conscious, and learning-oriented.

 
Why targeted training is more important than pure activity

Walks or general activity are useful, but often not enough to achieve lasting functional improvements.
Modern therapeutic approaches—such as GIGER® MD® therapy—therefore focus on:

• active, consciously controlled movement sequences,
• complex coordination and balance requirements,
• rhythmic and structured movement patterns,
• individually tailored training stimuli.
  
  

The aim is to specifically challenge the nervous system and stabilize functional abilities for as long as possible.
 

Connection with neuroplasticity

Even with Parkinson’s disease, the brain remains capable of learning. This adaptability is known as neuroplasticity.
Therapies such as GIGER® MD® therapy utilize this principle by:

• addressing several sensory and movement systems simultaneously,
• combining coordinative and rhythmic movements,
• actively promoting motor learning.

Neuroplasticity does not mean a cure, but rather better use of existing neural resources.

 
What are the limitations?

As important as targeted exercise therapy is, it is no substitute for medical treatment. Parkinson’s remains a progressive neurological disease. The goal is therefore not to cure the disease, but rather to:

• slow down functional decline,
• maintain quality of life for as long as possible,
• promote safety and independence in everyday life.

Therapeutic approaches such as GIGER® MD® therapy should be understood as complementary, supportive measures.

 
Conclusion

Parkinson’s disease is incurable. Nevertheless, those affected can actively contribute to positively influencing the functional course of the disease.
Regular, targeted exercise—especially in structured forms of therapy such as GIGER® MD® Therapy—can help maintain mobility, coordination, and safety in everyday life for longer.

Author: Combo AG, manufacturer and distributor of GIGER® MD® therapy Medical 

note: This article is for informational purposes only and does not replace medical advice or treatment.

Last update: 2026